Immunovia AB (publ) is a Sweden-based diagnostic company that is developing and commercializing blood tests for the early detection of cancer and autoimmune diseases based on Immunoviaâ€™s test platform called IMMray. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

11-05 Earnings release - Q3 2026

More about the company

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - OTC Markets 17:58:29 02/09/2026 +04			5-day change	1st Jan Change
0.0100 ^USD	-99.50%		0.00%	-50.00%

09-03	Six stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
09-01	17 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW

Market Cap	91.89M 9.32M 8.15M 7.66M 6.99M 13.11M 891M 13.12M 35.46M 455M 35.01M 34.24M 1.47B	P/E 2026 *	-1.37x	P/E 2027 *	-3.42x
Enterprise Value	56.89M 5.77M 5.04M 4.74M 4.33M 8.12M 552M 8.12M 21.95M 282M 21.67M 21.2M 908M	EV / Sales 2026 *	17.8x	EV / Sales 2027 *	3.58x
Free-Float	90.23%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Nasdaq Stockholm	IMMNOV	Delayed
CBOE	IMMNOs	Real-time
OTC Markets	IMMVF	Delayed
Boerse Muenchen	1YR	Real-time
CBOE	0G8X	Real-time
Deutsche Boerse AG	1YR	Delayed

09-03	Six stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
09-01	17 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
08-27	Nine stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
08-18	Seven stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
08-13	Immunovia: Strong demand for blood test for pancreatic cancer, survey shows	FW
08-07	Immunovia AB, Q2 2026 Earnings Call, Aug 06, 2026
08-06	Immunovia AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-06	Immunovia increased revenue and reduced its net loss	FW
08-06	Calendar, Thursday, August 6	FW
08-05	Calendar Thursday, August 6	FW
06-15	Immunovia Unveils New Data Ahead of Medicare Reimbursement Application	FW
06-15	Immunovia Announces New Performance Data for PancreaSure Ahead of Upcoming Application for Medicare Coverage	CI
06-10	Immunovia: Published study bolsters evidence for PancreaSure	FW

Immunovia AB Stock OTC Markets

Stocks

IMMVF

SE0006091997

Advanced Medical Equipment & Technology

Valuation: Immunovia AB

Chart: Immunovia AB

Latest news: Immunovia AB

Last Transcript: Immunovia AB

Analysts' recommendations: Immunovia AB

Press Releases: Immunovia AB

Quotes and Performance

Price Extremes

Managers and Directors: Immunovia AB

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quarterly revenue - Rate of surprise

26/02/25	Carlsquare initiates assignment monitoring of Immunovia	FW
30/12/23	Bonesupport winner of the year and Viaplay loser of the year on Nasdaq Stockholm 2023	FW

08-13	Immunovia presents survey data showing strong patient support for blood-based tests to detect pancreatic cancer at an earlier stage	AQ
08-06	Immunovia Publishes Interim Report for April-June 2026	AQ
08-03	Immunovia invites to a presentation on the Q2 report 2026	AQ
06-15	Immunovia announces new performance data for PancreaSure ahead of upcoming application for Medicare coverage	AQ
06-10	Immunovia publishes final AFFIRM study results in Journal of Clinical Oncology confirming strong diagnostic performance of PancreaSure	AQ

1 day	-99.50%
Current month	-50.00%
1 month	-50.00%
3 months	-50.00%
6 months	-50.00%
Current year	-50.00%

1 month	0.01	0.01
Current year	0.01	0.01
1 year	0.01	0.02
3 years	0.01	0.17
5 years	0.01	14.02
10 years	0.01	40

Manager	Title	Age	Since
Jeff Borcherding CEO	Chief Executive Officer	53	29/04/2023
Lisa Ford CTO	Chief Tech/Sci/R&D Officer	55	29/04/2024
Norma Alonzo Palma CTO	Chief Tech/Sci/R&D Officer	54	31/01/2024

Director	Title	Age	Since
Hans Olof Gunnar Johansson BRD	Director/Board Member	72	09/12/2016
Peter Andersen CHM	Chairman	69	26/05/2023
Martin Brygger Møller BRD	Director/Board Member	51	01/01/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMMUNOVIA AB	-99.50%	0.00%	-	-	9.75M
SARTORIUS AG	+1.73%	+6.04%	+20.65%	-20.42%	17.7B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	-1.16%	+1.67%	-39.25%	+27.84%	1.94B
ECKERT & ZIEGLER SE	+0.97%	+1.79%	-31.32%	+25.98%	887M
VAREX IMAGING CORPORATION	+0.05%	+0.05%	+51.48%	-1.86%	778M
QUIDELORTHO CORPORATION	+0.74%	+2.92%	-61.56%	-84.73%	745M
CONTEC MEDICAL SYSTEMS CO.,LTD	+3.71%	+8.73%	-31.21%	-46.60%	663M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	+1.30%	+2.27%	-39.31%	-52.07%	574M
908 DEVICES INC.	+2.76%	+12.14%	+48.08%	+85.10%	450M
REVENIO GROUP OYJ	-1.89%	-14.85%	-54.23%	-48.47%	438M
Average	-9.13%	+3.73%	-15.19%	-12.80%	2.69B
Weighted average by Cap.	+1.34%	+5.20%	+8.70%	-16.23%

	2026 *	2027 *
Net sales	3.2M 325K 284K 267K 243K 457K 31.03M 457K 1.23M 15.85M 1.22M 1.19M 51.09M	17.3M 1.75M 1.53M 1.44M 1.32M 2.47M 168M 2.47M 6.68M 85.68M 6.59M 6.45M 276M
Net income	-87M -8.83M -7.71M -7.25M -6.62M -12.42M -844M -12.42M -33.57M -431M -33.14M -32.42M -1.39B	-76M -7.71M -6.74M -6.33M -5.78M -10.85M -737M -10.85M -29.33M -376M -28.95M -28.32M -1.21B
Net Debt	-35M -3.55M -3.1M -2.92M -2.66M -4.99M -339M -5M -13.51M -173M -13.33M -13.04M -559M	-30M -3.04M -2.66M -2.5M -2.28M -4.28M -291M -4.28M -11.58M -149M -11.43M -11.18M -479M